Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Burning Rock Biotech (BNR) Invested Capital: 2019-2025

Historic Invested Capital for Burning Rock Biotech (BNR) over the last 1 years, with Jun 2025 value amounting to $825.1 million.

  • Burning Rock Biotech's Invested Capital was N/A to $825.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $825.1 million, marking a year-over-year change of. This contributed to the annual value of $79.6 million for FY2024, which is 26.48% down from last year.
  • Latest data reveals that Burning Rock Biotech reported Invested Capital of $825.1 million as of Q2 2025, which was up 936.94% from $79.6 million recorded in Q4 2024.
  • In the past 5 years, Burning Rock Biotech's Invested Capital ranged from a high of $825.1 million in Q2 2025 and a low of $79.6 million during Q4 2024.
  • Moreover, its 3-year median value for Invested Capital was $108.2 million (2023), whereas its average is $337.6 million.
  • Data for Burning Rock Biotech's Invested Capital shows a maximum YoY plummeted of 42.08% (in 2022) over the last 5 years.
  • Burning Rock Biotech's Invested Capital (Quarterly) stood at $289.9 million in 2021, then slumped by 42.08% to $167.9 million in 2022, then plummeted by 35.56% to $108.2 million in 2023, then decreased by 26.48% to $79.6 million in 2024, then reached $825.1 million in 2025.
  • Its last three reported values are $825.1 million in Q2 2025, $79.6 million for Q4 2024, and $108.2 million during Q4 2023.